Amy Jo-Nell Sehnert
Physician at Upper Ter, San Francisco, CA
License number
Colorado 33500
Issued Date
Apr 14, 1994
Renew Date
May 31, 1995
Expiration Date
May 31, 1995
Type
Physician
Address
Address
375 Upper Ter, San Francisco, CA 94117
Professional information
Vice President, Clinical Affairs At Verinata Health, Inc.
Position:
Vice President, Clinical Affairs at Verinata Health, Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Verinata Health, Inc.
- Redwood City, CA since Feb 2012
-
Vice President, Clinical Affairs
Verinata Health Inc
Mar 2010 - Feb 2012
-
Senior Director, Clinical Research
Stanford University
Oct 2006 - Feb 2010
-
Assistant Consulting Professor
CardioDx Inc.
Jan 2005 - Dec 2009
-
Director, Clinical R&D
UCSF
Jul 1999 - Aug 2006
-
Assistant Professor
Education:
University of California, San Francisco 1995 - 1999
University of Colorado Anschutz Medical Campus 1992 - 1995
Residency, Pediatrics University of Minnesota Medical School 1988 - 1992
MD, Medicine
University of Colorado Anschutz Medical Campus 1992 - 1995
Residency, Pediatrics University of Minnesota Medical School 1988 - 1992
MD, Medicine
Skills:
Clinical Research, Cell Culture, Cardiology, Biotechnology, Genetics, Healthcare Information Technology, Clinical Trials
Predictive Models And Methods For Diagnosing And Assessing Coronary Artery Disease
US Patent:
2011018, Jul 28, 2011
Filed:
Oct 10, 2008
Appl. No.:
12/682579
Inventors:
Steve Rosenberg - Oakland CA, US
Susan Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Amy J. Sehnert - San Francisco CA, US
Nicholas F. Paoni - Encinitas CA, US
Susan Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Amy J. Sehnert - San Francisco CA, US
Nicholas F. Paoni - Encinitas CA, US
Assignee:
CARDIODX, INC. - Palo Alto CA
International Classification:
G06G 7/60
US Classification:
703 11
Abstract:
Biomarkers useful for diagnosing and assessing the extent of coronary artery disease (CAD) are provided, along with kits for measuring their expression. The invention also provides predictive models, based on the biomarkers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples. In a preferred embodiment, the biomarkers are organized into clustered groups. The expression level of the biomarkers within a group are highly correlated to each other in normal and disease states. Expression values of genes chosen from each of two, three, four or five of the clustered gene groups, A, B, C, D, E may be used. Alternatively, expression values of genes chosen from the groups are combined into a metagene. Preferred biomarkers include S100A12, S100A8, S100A9, BCL2A1, and F5 (group A); XK, P62, and FECH (group B); TUBB2 (group C); IFNG, PDGFB, VSIG4, and TNF (group D); CSF3R, TLR5, CD46, and NCF1 (group E); S100A12, S100A9, BCL2A1, TXN and CSTA (group I); OLIG1, OLIG2, ADORA3, CLC, and SLC29A1 (group II); and CBS and ARG1 (group IV).
Dr. Amy Sehnert - MD (Doctor of Medicine)
Hospitals:
725 Welch Rd, Palo Alto 94304
STANFORD UNIVERSITY DEPARTMENT OF PEDIATRIC CARDIOLOGY
750 Welch Rd STE 305, Palo Alto 94304
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
725 Welch Rd, Palo Alto 94304
STANFORD UNIVERSITY DEPARTMENT OF PEDIATRIC CARDIOLOGY
750 Welch Rd STE 305, Palo Alto 94304
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
STANFORD UNIVERSITY DEPARTMENT OF PEDIATRIC CARDIOLOGY
750 Welch Rd STE 305, Palo Alto 94304
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
725 Welch Rd, Palo Alto 94304
STANFORD UNIVERSITY DEPARTMENT OF PEDIATRIC CARDIOLOGY
750 Welch Rd STE 305, Palo Alto 94304
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
Education:
Medical Schools
University of Mn Med Sch
Graduated: 1992
University of Mn Med Sch
Graduated: 1992
Determining Susceptibility To A Sudden Cardiac Event
US Patent:
2013001, Jan 10, 2013
Filed:
Mar 18, 2011
Appl. No.:
13/635018
Inventors:
Steven Rosenberg - Oakland CA, US
Michael R. Elashoff - Redwood City CA, US
John Lincoln Blanchard - Redwood City CA, US
Susan Elizabeth Daniels - Mountain View CA, US
James Alan Wingrove - Sunnyvale CA, US
Amy Jo-Nell Sehnert - San Francisco CA, US
Michael R. Elashoff - Redwood City CA, US
John Lincoln Blanchard - Redwood City CA, US
Susan Elizabeth Daniels - Mountain View CA, US
James Alan Wingrove - Sunnyvale CA, US
Amy Jo-Nell Sehnert - San Francisco CA, US
Assignee:
CARDIODX ,INC. - Palo Alto CA
International Classification:
G06F 19/10, C12Q 1/68
US Classification:
702 19, 435 611
Abstract:
Disclosed herein is a method of do terming the likelihood of a sudden cardiac event, such as an arrythmia, in a subject. Also disclosed is a method of determining whether a subject is at risk of a sudden cardiac event arid whether the subject would benefit from a treatment such as implantation of an ICD.